AgForce Enables Antigen-conditioned Generative Antibody Design

Mansoor Ahmed, Murray Patterson · 2026

Read AgForce Enables Antigen-conditioned Generative Antibody Design by Mansoor Ahmed, Murray Patterson (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/arxiv-2605-21610.txt.

Introduction

Mansoor Ahmed and Murray Patterson present AgForce for antigen-conditioned antibody design. Antibody design methods use antigen structure to make complementarity-determining regions. Yet systematic review of base methods reveals they ignore antigen input. They identify three failure modes. First, antigen blindness: models derive guesses from immune frame context rather than antigen information. Second, word collapse: guessed amino acids fall to three to five per spot. Third, the argmax block on cross-entropy loss via greedy reading acts as a null guesser seeing only spot and loop length.

Catalog record

CREATORMansoor Ahmed, Murray Patterson
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE71760
LICENSEhttp://creativecommons.org/licenses/by/4.0/
RIGHTSCC BY
SOURCEarXiv

Source: https://arxiv.org/abs/2605.21610

Browse the full library · About the Tower of Babel

Full text

The opening of the work, from the library's hosted text:

AgForce Enables Antigen-conditioned Generative Antibody Design Mansoor Ahmed, Murray Patterson Abstract Antibody design methods condition on antigen structure to generate complementarity-determining regions (CDR), yet a systematic evaluation of baseline methods reveals that they largely ignore the antigen input. We identify three failure modes that explain this behavior. Antigen blindness arises because models derive predictions from antibody framework context rather than antigen information, producing nearly identical CDRs regardless of the target. Vocabulary collapse reduces predicted amino acids to three to five per position, far below the ground truth distribution in native sequences. Moreover, any model trained with standard per-position cross-entropy converges to the positional marginal distribution, making it provably unable to produce antigen-specific sequence predictions. We propose a novel encoder-decoder architecture called AgForce , that uses a graph neural network (GNN) as the encoder and specialized decoders for sequence-structure co-design. Specifically, we apply framework dropout, gated bottlenecks, and hyperbolic cross attention that prevent the antibody shortcut path. In the decoder, a Mixture Density Network (MDN) sequence head with Potts-like pairwise coupling and annealed Multiple Choice Learning (aMCL) replaces the cross-entropy objective with a multi-component distribution whose optimal solution differs from the positional marginal. An antigen cycle consistency head routes gradients through the sequence decoder, forcing predicted distributions to encode antigen identity. AgForce achieves the best binding quality and sequence recovery simultaneously on the Chimera-Bench benchmark, improving amino acid recovery by 8% over the strongest sequence baseline while surpassing the baselines across all interface metrics, and nearly doubling the effective vocabulary of GNN methods. The source code is available at: https://github.com/mansoor181/ag-force.git 1 Introduction Antibodies recognize and neutralize foreign antigens through their complementarity-determining regions (CDRs), six hypervariable loops that form the primary binding interface ( 24 ) . Among these, CDR-H3 exhibits the greatest sequence and structural diversity and contributes most to antigen specificity ( 9 ) . Designing CDR sequences and backbone structures that bind a target epitope is a central challenge in therapeutic antibody engineering ( 12 ) , and a growing body of deep generative models now address this problem by conditioning on antigen structure ( 20 ; 16 ; 17 ; 29 ; 32 ; 1 ; 27 ) . A natural expectation is that conditioning on the antigen should produce designs tailored to the target. Recent evidence suggests otherwise: unigram frequency alone explains most predictions ( 17 ) , BLOSUM substitution scores predict model outputs as well as learned likelihoods ( 28 ) , removing the antigen chain leaves predictions nearly unchanged ( 19 ) , and including the antigen sequence does not improve design quality ( 15 ) . These findings point to a systematic failure of existing conditioning mechanisms, but no prior work has identified the root causes or proposed principled remedies. We diagnose three causally linked failure modes that explain why the strongest CDR design paradigm, equivariant graph neural networks with greedy decoding, fails to condition on antigen information. Antigen blindness : all methods we evaluate show substantially lower recovery at antigen-contacting positions than non-contacting positions, and an antigen-free baseline achieves the strongest binding quality, confirming that existing conditioning mechanisms contribute little. Vocabulary collapse : GNN methods with greedy decoding produce effective vocabularies of three to five amino acids per position, far below native diversity, with rare but biochemically important residues almost never predicted. The cross-entropy ceiling provides a unifying explanation: the standard per-position cross-entropy loss has its optimum at the positional marginal distribution regardless of conditioning signal, forcing the model to ignore the antigen and concentrate on a few amino acids per position. Figure 1 : (a) Vocabulary collapse: Heatmap of the ground truth amino acid distribution of CDR H3, the predictions by dyMEAN, and our proposed model, AgForce . (b) AAR vs. effective vocabulary. To address these failure modes, we introduce a novel encoder-decoder architecture called AgForce , that uses an E(3) graph neural network (EGNN) as the encoder and specialized decoders for sequence-structure co-design. The decoder employs a mixture density network with Potts-like pairwise coupling, and annealed multiple choice learning replaces the standard sequence head, provably breaking the cross entropy ceiling by enabling component specialization. Similarly, a framework dropout module corrupts the antibody context during training, and an antigen consistency head routes gradients through the sequence decoder to enforce antigen conditioning. For vocabulary collapse, the multi-component MDN permits diverse predictions across components, and GDPP spectral regularization penalizes deviations from native diversity. Our contributions: 1. A diagnostic framework identifying three causally linked failure modes in equivariant GNN methods for CDR design that per-position cross-entropy cannot produce antigen-specific predictions, verified empirically across baselines spanning five architectural families. 2. AgForce , which introduces targeted interventions for each diagnosed failure: an MDN-Potts sequence head with aMCL training, framework dropout, and an antigen consistency loss, and virtual-node-augmented equivariant message passing with hyperbolic cross-attention. On the Chimera-Bench benchmark, AgForce achieves the best binding quality and sequence recovery simultaneously, improving amino acid recovery by 8% over the strongest sequence baseline while surpassing the strongest binding baseline across all interface metrics, and nearly doubling the effective vocabulary of GNN methods. 2 Related Work Equivariant GNN methods. MEAN ( 16 ) formulates CDR design as E(3)-equivariant graph translation with multi-channel attention. dyMEAN ( 17 ) extends this to full-atom design with a shadow paratope loss. RAAD ( 32 ) adds relation-aware edge features and a contrastive specificity loss. These methods condition on antigen through spatial message passing and achieve the highest sequence recovery among all paradigms. RefineGNN ( 14 ) generates CDRs autoregressively without any antigen input, yet achieves the best binding metrics among all baselines. Multiple independent studies corroborate this conditioning failure: BLOSUM substitution scores predict model outputs as accurately as learned likelihoods ( 28 ) , removing the antigen chain leaves predictions nearly unchanged ( 19 ) , and a BLOSUM lookup table outperforms deep learning methods in binder enrichment ( 8 ) . While these studies document the problem, they fall short of identifying the root causes and proposing methodological interventions. Diffusion, flow, and ODE methods. DiffAb ( 20 ) models CDR generation as diffusion on SE(3) \times categorical, while AbFlowNet ( 1 ) replaces diffusion with GFlowNet trajectory balance. AbMEGD ( 7 ) adds multi-scale encoding, dyAb ( 27 ) applies flow matching, AbODE ( 29 ) uses conjoined ODEs, and RADAb ( 30 ) augments diffusion with retrieval. FlowDesign ( 31 ) follows a diagnose-then-fix approach similar to ours. These sampling-based methods maintain higher amino acid diversity but achieve substantially lower sequence recovery than GNN methods. Multi-modal sequence prediction and conditioning. TERMinator ( 18 ) derives Potts energy tables from a GNN encoder for MCMC-based sequence design. PottsMPNN ( 5 ) adds pairwise Potts supervision to ProteinMPNN, improving thermodynamic stability beyond what native sequence recovery captures. Mixture density networks ( 6 ) model multi-modal distributions but have not been applied to discrete amino acid prediction. Annealed multiple choice learning ( 23 ) addresses winner-take-all collapse in hypothesis ensembles but has not been applied to biological sequences. Our MDN-Potts head combines these: mixture components with learned coupling matrices are decoded by belief propagation and trained via aMCL end-to-end. For conditioning, classifier-free guidance ( 11 ) drops the conditioning signal during training to enforce genuine conditional distributions, but

Read the complete text